Takahiko Suzuki
发表
Y. Mitsui,
H. Hoshi,
Takahiko Suzuki,
1990,
FEBS letters.
K. Ohtomo,
Y. Hosoi,
Y. Matsumoto,
2004,
Biochemical and biophysical research communications.
Y. Kakinuma,
I. Yamaguchi,
T. Miyauchi,
2002,
Clinical science.
T. Kumazaki,
Y. Mitsui,
Takahiko Suzuki,
1995
.
Y. Mitsui,
K. Kitani,
Takahiko Suzuki,
1997,
Neuroscience Letters.
Y. Mitsui,
Takahiko Suzuki,
1994
.
H. Hoshi,
Takahiko Suzuki,
M. Ohta,
1989,
In Vitro Cellular & Developmental Biology.
Y. Mitsui,
Takahiko Suzuki,
S. Katoh,
1997,
In Vitro Cellular & Developmental Biology - Animal.
S. Kojima,
H. Kohno,
Y. Ohkubo,
2004,
European Journal of Nuclear Medicine.
J. Kobayashi,
T. Umeda,
Yoshiko Kobayashi,
2016
.
K. Miyagawa,
M. Katsura,
Takahiko Suzuki,
2014,
Nature Communications.
K. Ohtomo,
Y. Hosoi,
Y. Matsumoto,
2004,
Radiation research.
K. Kisara,
Takahiko Suzuki,
1985,
Pharmacology Biochemistry and Behavior.
Y. Kakinuma,
I. Yamaguchi,
T. Miyauchi,
2001,
Journal of cardiovascular pharmacology.
K. Onodera,
K. Takano,
K. Kisara,
1981
.
Y. Mitsui,
K. Kitani,
Takahiko Suzuki,
1999
.
H. Kohno,
Y. Ohkubo,
A. Kubodera,
2004,
European Journal of Nuclear Medicine.
K. Ohtomo,
Y. Hosoi,
Y. Matsumoto,
2006,
Cell Death and Differentiation.
S. Yamaguchi,
T. Suzuki,
H. Tomoike,
2000,
Journal of molecular and cellular cardiology.
A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes.
T. Miyauchi,
Takahiko Suzuki,
T. Suzuki,
2001,
American journal of physiology. Regulatory, integrative and comparative physiology.